Patent: 10,100,130
✉ Email this page to a colleague
Summary for Patent: 10,100,130
Title: | Dual specificity antibody fusions |
Abstract: | The present invention provides dual specificity antibody fusion proteins comprising an antibody Fab or Fab\' fragment with specificity for an antigen of interest, said fragment being fused to at least one single domain antibody which has specificity for a second antigen of interest. |
Inventor(s): | Humphreys; David Paul (Slough, GB), Dave; Emma (Slough, GB), Griffin; Laura (Slough, GB), Heywood; Sam Philip (Slough, GB) |
Assignee: | UCB BIOPHARMA SPRL (Brussels, BE) |
Application Number: | 15/792,373 |
Patent Claims: | see list of patent claims |
Details for Patent 10,100,130
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2027-09-26 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2027-09-26 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2027-09-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |